Apr 25, 2012 | Business Journal
Nodality loses leader to NEA as medical diagnostics model morphs
Growing diagnostic test developer Nodality Inc. is losing its first CEO , but the venture capital world is gaining another experienced life sciences entrepreneur.
Apr 25, 2012 | Freshnews
Zyngenia, Inc. Recruits David Parkinson, M.D., as Board Member,...
GAITHERSBURG, Md., April 25, 2012 /PRNewswire/ -- Zyngenia, Inc ., a biopharmaceutical company developing Zybodies , next-generation multi-specific antibody-based drugs in oncology and immunology, announced today that it has appointed David Parkinson, M.D. as a member of its Board of Directors and head of its Clinical Advisory Board.